Phase II Study of Repeated Single 24-Hour Infusion of Low-Dose 5-Fluorouracil for Palliation in Symptomatic Hormone-Refractory Prostate Cancer

Urologia Internationalis ◽

10.1159/000066118 ◽

2002 ◽

Vol 69 (4) ◽

pp. 273-277 ◽

Author(s):

A. Bex ◽

T. Otto ◽

G. Lümmen ◽

H. Rübben

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase II Study of Vinorelbine and Low-Dose Docetaxel in Chemotherapy-Naive Patients with Hormone-Refractory Prostate Cancer

The Cancer Journal ◽

10.1097/00130404-200307000-00011 ◽

2003 ◽

Vol 9 (4) ◽

pp. 286-292 ◽

Author(s):

Alan J. Koletsky ◽

Manuel L. Guerra ◽

Lori Kronish

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

A PHASE II STUDY OF DOCETAXEL, ESTRAMUSTINE, AND LOW DOSE HYDROCORTISONE IN HORMONE REFRACTORY PROSTATE CANCER

The Journal of Urology ◽

10.1097/00005392-199904020-00186 ◽

1999 ◽

pp. 296 ◽

Author(s):

Diane Savarese ◽

Mary-Ellen Taplin ◽

Bonnie Marchesani ◽

Willi Kreis ◽

Wallace Akerley ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

UP-2.126: Low Dose Metronomic Oral Combined Administration of Etoposide and Cyclophosphamide in Metastatic Hormone Refractory Prostate Cancer After Docetaxol or Mitoxantrone Chemotherapy: A Phase II Study in China

Urology ◽

10.1016/j.urology.2009.07.345 ◽

2009 ◽

Vol 74 (4) ◽

pp. S270

Author(s):

Y. Shen ◽

D. Ye ◽

X. Yao ◽

S. Zhang ◽

B. Dai ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Combined Administration ◽

Hormone Refractory

Download Full-text

Phase II study of low dose (weekly) docetaxel and estramustine in elderly males (age ≥75 years) with hormone-refractory prostate cancer or patients age 18 to 74 years with an ECOG performance status of 2 or 3

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4646 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4646-4646 ◽

Author(s):

S. R. Chittoor ◽

W. R. Berry ◽

D. M. Loesch ◽

K. W. Logie ◽

J. Fleagle ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Performance Status ◽

Hormone Refractory Prostate Cancer ◽

Ecog Performance Status ◽

Weekly Docetaxel ◽

Elderly Males ◽

Hormone Refractory

Download Full-text

Phase II Study of Low-Dose Docetaxel/Estramustine in Elderly Patients or Patients Aged 18-74 Years with Hormone-Refractory Prostate Cancer

Clinical Genitourinary Cancer ◽

10.3816/cgc.2006.n.039 ◽

2006 ◽

Vol 5 (3) ◽

pp. 212-218 ◽

Author(s):

Sreeni Chittoor ◽

William Berry ◽

David Loesch ◽

Keith Logie ◽

John Fleagle ◽

...

Keyword(s):

Prostate Cancer ◽

Elderly Patients ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81827-9 ◽

1999 ◽

Vol 35 ◽

pp. S349 ◽

Author(s):

A. Einstein ◽

R. Lush ◽

R. Rago ◽

G. Bubley ◽

W.D. Henner ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Line Treatment ◽

Hormone Refractory ◽

First Line Treatment

Download Full-text

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Cancer ◽

10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x ◽

1993 ◽

Vol 72 (6) ◽

pp. 1965-1968 ◽

Author(s):

Timothy M. Kuzel ◽

Martin S. Tallman ◽

Daniel Shevrin ◽

Edward Braud ◽

Lary Kilton ◽

...

Keyword(s):

Prostate Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Cancer Center ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Download Full-text

Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer

Oncology Reports ◽

10.3892/or.10.4.885 ◽

2003 ◽

Author(s):

C. Robles ◽

A. Furst ◽

P. Sriratana ◽

S. Lai ◽

L. Chua ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Metastatic Prostate Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory ◽

Dose Prednisone

Download Full-text

Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)

Investigational New Drugs ◽

10.1023/b:drug.0000047109.76766.84 ◽

2005 ◽

Vol 23 (1) ◽

pp. 79-84 ◽

Author(s):

Tahir Latif ◽

Laura Wood ◽

Cindy Connell ◽

David C. Smith ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text